Skip to main content
Top
Gepubliceerd in: Tijdschrift voor Gerontologie en Geriatrie 3/2009

01-06-2009 | Klinische les

Progressieve Supranucleaire Verlamming. Interventie middels acetylcholineesteraseremmer?

Auteurs: H. Nijboer, P. L. J. Dautzenberg

Gepubliceerd in: Tijdschrift voor Gerontologie en Geriatrie | Uitgave 3/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Progressive supranucleair verlamming (PSP) is een zeldzame, ernstige progressieve neurologische aandoening met complexe symptomatologie. Wij beschrijven een 3-tal casussen, die in de periode 2005-2008 zijn vervolgd. Ondanks de aanwezigheid van internationale criteria sinds 1996, zijn de diagnosestelling en behandeling nog steeds moeilijk. In deze 3 casussen is gekozen voor rivastigmine; redenen daarvoor worden kort toegelicht. Onder het gebruik van rivastigmine zijn cognitieve stoornissen nauwelijks toegenomen. Meer onderzoek hiernaar lijkt aangewezen.
Literatuur
1.
go back to reference Lubarksy M and Juncos JL. Progressive supranuclear palsy: a current review. Neurologist. 2008 Mar;14(2):79-882 Lubarksy M and Juncos JL. Progressive supranuclear palsy: a current review. Neurologist. 2008 Mar;14(2):79-882
2.
go back to reference Litvan I, Agid Y, Calne D, Campbell G et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.Neurology. 1996 Jul;47(1):1-9. Litvan I, Agid Y, Calne D, Campbell G et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.Neurology. 1996 Jul;47(1):1-9.
3.
go back to reference Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-59 Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-59
4.
go back to reference Friedman DI, Jankovic J, McCrary JA. Neuro-ophthalmic findings in progressive supranuclear palsy. J Clin Neuro Ophthalmol 1992; 12:104-9. Friedman DI, Jankovic J, McCrary JA. Neuro-ophthalmic findings in progressive supranuclear palsy. J Clin Neuro Ophthalmol 1992; 12:104-9.
5.
go back to reference Oba H, Yagishita A, Terada H et al New and reliable MRI diagnosis for progressive supranuclear palsy.Neurology. 2005 Jun 28;64(12):2050-5. Oba H, Yagishita A, Terada H et al New and reliable MRI diagnosis for progressive supranuclear palsy.Neurology. 2005 Jun 28;64(12):2050-5.
6.
go back to reference Maher ER, Lees AJ. The clinical features and natural history of the Steel-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986;36:1005-8. Maher ER, Lees AJ. The clinical features and natural history of the Steel-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986;36:1005-8.
7.
go back to reference Tackmann W. Die progressive supranukleare Lahmung. Schweiz Rundsch Med Prax 1992;81:1534-7. Tackmann W. Die progressive supranukleare Lahmung. Schweiz Rundsch Med Prax 1992;81:1534-7.
8.
go back to reference Alemdar M, Kamaci S, Budak F. Unilateral midbrain infarction causing upward and downward gaze palsy.J Neuroophthalmol. 2006 Sep;26(3):173-6. Alemdar M, Kamaci S, Budak F. Unilateral midbrain infarction causing upward and downward gaze palsy.J Neuroophthalmol. 2006 Sep;26(3):173-6.
9.
go back to reference Huber FM, Bour F, Sazdovitch V et al Creutzfeldt-Jakob disease with slow progression. A mimickry of progressive supranuclear palsy. Bull Soc Sci Med Grand Duche Luxemb. 2007;(2):125-30 Huber FM, Bour F, Sazdovitch V et al Creutzfeldt-Jakob disease with slow progression. A mimickry of progressive supranuclear palsy. Bull Soc Sci Med Grand Duche Luxemb. 2007;(2):125-30
10.
go back to reference Prasad S, Ko MW, Lee EB et al. Supranuclear vertical gaze abnormalities in sporadic Creutzfeldt-Jakob disease, J Neurol Sci. 2007 Feb 15;253(1-2):69-72. Prasad S, Ko MW, Lee EB et al. Supranuclear vertical gaze abnormalities in sporadic Creutzfeldt-Jakob disease, J Neurol Sci. 2007 Feb 15;253(1-2):69-72.
11.
go back to reference Clerici F, Ratti PL, Pomati S, Maggiore L, Dementia with Lewy bodies with supranuclear gaze palsy: a matter of diagnosis. Neurol Sci. 2005 Dec;26(5):358-61 Clerici F, Ratti PL, Pomati S, Maggiore L, Dementia with Lewy bodies with supranuclear gaze palsy: a matter of diagnosis. Neurol Sci. 2005 Dec;26(5):358-61
12.
go back to reference Brett FM, Henson C, Staunton H. Familial diffuse Lewy body disease, eye movement abnormalities, and distribution of pathology.Arch Neurol. 2002 Mar;59(3):464-7. Brett FM, Henson C, Staunton H. Familial diffuse Lewy body disease, eye movement abnormalities, and distribution of pathology.Arch Neurol. 2002 Mar;59(3):464-7.
13.
go back to reference Kristensen MO. Progressive supranuclear palsy – 20 years later. Acta Neurol Scand 1985;71:177-89. Kristensen MO. Progressive supranuclear palsy – 20 years later. Acta Neurol Scand 1985;71:177-89.
14.
go back to reference Litvan I, Agid Y, Calne D, Campbell G et al Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.Neurology. 1996 Jul;47(1):1-9. Review. Litvan I, Agid Y, Calne D, Campbell G et al Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.Neurology. 1996 Jul;47(1):1-9. Review.
15.
go back to reference Maher ER. Smith EM, Lees AJ. Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry 1985;48:1234-9. Maher ER. Smith EM, Lees AJ. Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry 1985;48:1234-9.
16.
go back to reference Perkin GD, Lees AJ, Stern GM, Kocen RS. Problems in the diagnosis of PSP (Steele-Richardson-Olszewski-syndrome). Can J Neurol 1964;10:333-59. Perkin GD, Lees AJ, Stern GM, Kocen RS. Problems in the diagnosis of PSP (Steele-Richardson-Olszewski-syndrome). Can J Neurol 1964;10:333-59.
17.
go back to reference Ward C.Characteristics and symptom management of progressive supranuclear palsy: a multidisciplinary approach. J Neurosci Nurs. 2006 Aug;38(4):242-7. Review. Ward C.Characteristics and symptom management of progressive supranuclear palsy: a multidisciplinary approach. J Neurosci Nurs. 2006 Aug;38(4):242-7. Review.
18.
go back to reference Nieforth KA, Golbe LI. Retrospective study of drug response in 87 patients with progressive supranuclear paisy. Clin Neuropharmacol 1993;16:338-46. Nieforth KA, Golbe LI. Retrospective study of drug response in 87 patients with progressive supranuclear paisy. Clin Neuropharmacol 1993;16:338-46.
19.
go back to reference Daniele A, Moro E, Bentivoglio AR.Zolpidem in progressive supranuclear palsy.N Engl J Med. 1999 Aug 12;341(7):543-4. Daniele A, Moro E, Bentivoglio AR.Zolpidem in progressive supranuclear palsy.N Engl J Med. 1999 Aug 12;341(7):543-4.
20.
go back to reference Kasashima S, Oda Y.Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 2003 Feb;105(2):117-24. Kasashima S, Oda Y.Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 2003 Feb;105(2):117-24.
21.
go back to reference Fabbrini G, Barbanti P, Bonifati V et al Donepezil in the treatment of progressive supranuclear palsy.Acta Neurol Scand. 2001 Feb;103(2):123-5. Fabbrini G, Barbanti P, Bonifati V et al Donepezil in the treatment of progressive supranuclear palsy.Acta Neurol Scand. 2001 Feb;103(2):123-5.
22.
go back to reference Bullock R, Lane R Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase.Curr Alzheimer Res. 2007 Jul;4(3):277-93. Bullock R, Lane R Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase.Curr Alzheimer Res. 2007 Jul;4(3):277-93.
23.
go back to reference Moretti R, Torre P, Antonello RM et al Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients.Am J Alzheimers Dis Other Demen. 2003 Sep-Oct;18(5):265-72. Moretti R, Torre P, Antonello RM et al Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients.Am J Alzheimers Dis Other Demen. 2003 Sep-Oct;18(5):265-72.
Metagegevens
Titel
Progressieve Supranucleaire Verlamming. Interventie middels acetylcholineesteraseremmer?
Auteurs
H. Nijboer
P. L. J. Dautzenberg
Publicatiedatum
01-06-2009
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Gerontologie en Geriatrie / Uitgave 3/2009
Print ISSN: 0167-9228
Elektronisch ISSN: 1875-6832
DOI
https://doi.org/10.1007/BF03079574

Andere artikelen Uitgave 3/2009

Tijdschrift voor Gerontologie en Geriatrie 3/2009 Naar de uitgave

Recente onderzoeksliteratuur

Recente onderzoeksliteratuur

Signalementen

Signalementen

Congresagenda

Agenda

Boekbesprekingen

Boekbesprekingen